Newbridge Financial Services Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-32
Closed -$394 – 1271
2023
Q3
$394 Hold
32
– – ﹤0.01% 1214
2023
Q2
$514 Hold
32
– – ﹤0.01% 1260
2023
Q1
$557 Hold
32
– – ﹤0.01% 1316
2022
Q4
$296 Hold
32
– – ﹤0.01% 1377
2022
Q3
$0 Hold
32
– – ﹤0.01% 1442
2022
Q2
$0 Hold
32
– – ﹤0.01% 1465
2022
Q1
$0 Hold
32
– – ﹤0.01% 1513
2021
Q4
$1K Hold
32
– – ﹤0.01% 1345
2021
Q3
$2K Hold
32
– – ﹤0.01% 1187
2021
Q2
$1K Hold
32
– – ﹤0.01% 1373
2021
Q1
$2K Buy
+32
New +$1.67K ﹤0.01% 1181

Other funds holding NEO

Newbridge Financial Services Group's NEO Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 32 shares — an estimated $394 sold.

Newbridge Financial Services Group first reported a position in NEO in Q1 2021 and held it in 11 quarters. The position peaked at $2K in Q3 2021. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 32 NeoGenomics shares in Q4 2023, an estimated $394.
  • Newbridge Financial Services Group first reported a position in NeoGenomics in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's NeoGenomics position peaked at $2K in Q3 2021.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.